RFK Jr. Asked FDA to Nix COVID Vaccine During Pandemic
Vaccine skeptic and nominee to be Donald Trump’s secretary of the Department of Health and Human Services, Robert F. Kennedy, ...
FDA pauses updates on food-borne outbreak probes as health agencies regroup on communications
The Trump administration's "short pause" on communications, expected to end on Feb. 1, has affected FDA updates on food ...
Newly FDA-approved COVID-19 treatment helps protect immunocompromised
A big step forward in COVID-19 treatment and a breakthrough for a Florida-based nonprofit blood center serving the southeast. OneBlood just became the first blood center to get full FDA approval to ...
RFK Jr. petitioned FDA in 2021 to revoke authorization of all COVID vaccines
Robert F. Kennedy Jr., who's nominated to become the next health secretary, asked the federal government to revoke its authorization of all COVID-19 vaccines in May 2021, just as vaccinated Americans ...
Kennedy sought to stop COVID-19 vaccinations 6 months after rollout
Robert F. Kennedy Jr. petitioned the FDA to revoke authorization of the shots when they were in high demand and thousands of ...
RFK Jr. Tried to Kill the Covid Vaccine When It Was Needed Most
Robert F. Kennedy Jr. petitioned the FDA to revoke its authorization for the Covid-19 vaccine just six months after it was ...
Medpage Today on MSN2d
Anti-Abortion Groups' Secret Weapon; Kennedy Targeted COVID Vax; Research at Risk
One strategy antiabortion advocates may increasingly rely upon as they attempt to block medication abortion from reaching ...
STAT3d
Three former FDA officials: Here’s what Trump and his nominees need to know
The FDA is the leading science-based consumer protection agency in the world. Three former senior officials write about what ...
New Atlas10h
New AI picks up 97% of lung diseases, and can tell pneumonia from COVID-19
A breakthrough new AI model is able to detect the presence of different lung diseases from ultrasound videos, with 96.57% ...
Novavax Cashes In On Its COVID Albatross -- Challenges Remain (Rating Upgrade)
With its significant cash infusions from offloading its COVID assets, Novavax had just over $1 billion as it exited Q3, 2024.
Fact Check: Rise in under-50s cancer diagnoses predates COVID-19 vaccines
Rising diagnoses of certain cancers in people under 50 predate the rollout of COVID-19 vaccines by decades, undermining ...